Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Melling

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|August 31, 2021
Robotic rectal resection preserves anorectal function: Systematic review and meta-analysisJulia K Grass, Chien-Chih Chen, Nathaniel Melling, et al.
JAMA Network Open|August 17, 2023
Second Primary Cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl DisasterAnas Taha, Stephanie Taha-Mehlitz, Eldar A Nadyrov, et al.
Cancers|January 23, 2024
A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal AdenocarcinomaBaris Mercanoglu, Karl-Frederick Karstens, Anastasios D Giannou, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Oncology Letters|March 19, 2019
p53 overexpression is a prognosticator of poor outcome in esophageal cancerNathaniel Melling, Sonja Norrenbrock, Martina Kluth, et al.
Oncotarget|April 8, 2020
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinomaFrank Jacobsen, Jacob Kohsar, Florian Gebauer, et al.
Carcinogenesis|September 23, 2015
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersNathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, et al.
Scientific Reports|November 29, 2024
GalNT2-mediated O-glycosylation affects pancreas development and function in miceBaris Mercanoglu, Sissy-Alina Waschkowski, Elena Neuburg, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|August 31, 2021
Robotic rectal resection preserves anorectal function: Systematic review and meta-analysisJulia K Grass, Chien-Chih Chen, Nathaniel Melling, et al.
JAMA Network Open|August 17, 2023
Second Primary Cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl DisasterAnas Taha, Stephanie Taha-Mehlitz, Eldar A Nadyrov, et al.
Cancers|January 23, 2024
A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal AdenocarcinomaBaris Mercanoglu, Karl-Frederick Karstens, Anastasios D Giannou, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Oncology Letters|March 19, 2019
p53 overexpression is a prognosticator of poor outcome in esophageal cancerNathaniel Melling, Sonja Norrenbrock, Martina Kluth, et al.
Oncotarget|April 8, 2020
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinomaFrank Jacobsen, Jacob Kohsar, Florian Gebauer, et al.
Carcinogenesis|September 23, 2015
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersNathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, et al.
Scientific Reports|November 29, 2024
GalNT2-mediated O-glycosylation affects pancreas development and function in miceBaris Mercanoglu, Sissy-Alina Waschkowski, Elena Neuburg, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.
Pageof 10